Revealing the Latest Prostate Cancer Insights and Innovation at AUA2024!

MyProstateScore 2.0 (MPS2) is the only biomarker test with 99% negative predictive value (NPV) for the prediction of Grade Group ≥2 prostate cancer in patients with a previous negative biopsy.

Come see us at Booth #801 during AUA2024 and discover how a 30-second urine sample offers unparalleled insights to guide your patients through prostate cancer risk assessment.